On 29 October 2015
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 2015, to consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half Year ended 30 September 2015 (Q2).Powered by Capital Market - Live News